Abstract
We describe here two infertile male patients who were referred to our hospital with azoospermia at the ages of 33 and 30 years, respectively. Hormonal examinations led to a diagnosis of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency in both patients. Genotyping revealed that the patients had a homozygous I172N and a heterozygous compound I172N/IVS2-13A/C>G mutation, respectively. Glucocorticoid replacement therapy succeeded in improving the seminal status of one patient, but not the other. For the latter patient and his wife, a pregnancy was achieved by testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) following genetic counseling. It is important to investigate genotyping and to classify patients on the basis of genotypic information in order to arrive at better treatment strategies for male infertility; especially in counseling of TESE-ICSI.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jaaskelainen J, Levo A, Voutilainen R, Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab 1997; 82:3293–7
New MI. An update of congenital adrenal hyperplasia. Ann N Y Acad Sci 2004; 1038:14–43
Bonaccorsi AC, Adler I, Figueiredo JG. Male infertility due to congenital adrenal hyperplasia: testicular biopsy findings, hormonal evaluation, and therapeutic results in three patients. Fertil Steril 1987; 47:664–70
Murphy H, George C, de Kretser D, Judd S. Successful treatment with ICSI of infertility caused by azoospermia associated with adrenal rests in the testes: case report. Hum Reprod 2001; 16:263–7
Tiitinen A, Valimaki M. Primary infertility in 45-year-old man with untreated 21-hydroxylase deficiency: successful outcome with glucocorticoid therapy. J Clin Endocrinol Metab 2002; 87:2442–5
Wischusen J, Baker HW, Hudson B. Reversible male infertility due to congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 1981; 14:571–7
Mirsky HA, Hines JH. Infertility in a man with 21-hydroxylase deficient congenital adrenal hyperplasia. J Urol 1989; 142:111–3
Augarten A, Weissenberg R, Pariente C, Sack J. Reversible male infertility in late onset congenital adrenal hyperplasia. J Endocrinol Invest 1991; 14:237–40
Iwamoto T, Yajima M, Tanaka H, Minagawa N, Osada T. A case report: reversible male infertility due to congenital adrenal hyperplasia. Nippon Hinyokika Gakkai Zasshi 1993; 84:2031–4 (Japanese)
Kalachanis I, Rousso D, Kourtis A, Goutzioulis F, Makedos G, Panidis D. Reversible infertility, pharmaceutical and spontaneous, in a male with late onset congenital adrenal hyperplasia, due to 21-hydroxylase deficiency. Arch Androl 2002; 48: 37–41
Speiser PW, Dupont B, Rubinstein P and New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37:650–67
Acknowledgements
This work was supported by a financial support from Takeda Science Foundation and Smoking Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Additional information
Genotypic information of CAH patients is important in the treatment for male infertility, especially in counseling of TESE-ICSI.
Rights and permissions
About this article
Cite this article
Sugino, Y., Usui, T., Okubo, K. et al. Genotyping of congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as male infertility: Case report and literature review. J Assist Reprod Genet 23, 377–380 (2006). https://doi.org/10.1007/s10815-006-9062-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-006-9062-0